In colorectal cancer (CRC) screening, stool blood tests and measurement of tumor markers in serum, such as carcinoembryonic antigen (CEA) and carbohydrate antigen (CA19-9), are conventional methods that have been used. Here, CEACAM5 is linked to colorectal carcinoma.